HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Monitoring myocardial performance after open heart surgery by calculation of diastolic and systolic pressure time index (author's transl)].

Abstract
In order to determine the incidence of subendocardial ischemia after open heart surgery, subendocardial blood flow was monitored in 171 patients subjected to mitral and/or aortic valve replacement or coronary revascularization by on-line calculation of Diastolic (DPTI) and Systolic Pressure Time Index (TTI). Body hypothermia with an esophageal temperature of 25 degrees C and magnesium-aspartate-procaine cardioplegia were applied for myocardial protection. Ten patients developed low cardiac output state with two early deaths. In the two patients with fatal low cardiac output DPTI/TTI remained below 0.8. In the remaining 8 patients DPTI/TTI rose to 1.4 after a mean recovery time of 36 hours. In 161 patients (94%) no low cardiac output state evolved and DPTI/TTI rose to 1.3 within 60 min. after termination of cardiopulmonary bypass. Our results indicate that body hypothermia of 25 degrees C combined with magnesium-aspartate-procaine cardioplegia can reduce the incidence of subendocardial ischemia, but does not prevent this complication completely after anoxic times beyond 60-70 minutes.
AuthorsW Seybold-Epting, G Fenchel, R Stunkat, H Seboldt, H E Hoffmeister
JournalThoraxchirurgie, vaskulare Chirurgie (Thoraxchir Vask Chir) Vol. 26 Issue 5 Pg. 348-52 (Oct 1978) ISSN: 0040-6384 [Print] Germany
Vernacular TitleUberwachung der Myokardfunktion nach offenen Herzoperationen durch Messung des diastolischen und systolischen Druck-Zeit-Index.
PMID715754 (Publication Type: English Abstract, Journal Article)
Topics
  • Blood Pressure
  • Cardiac Output
  • Cardiac Surgical Procedures (adverse effects)
  • Coronary Disease (surgery)
  • Heart Arrest, Induced (methods)
  • Heart Valve Diseases (surgery)
  • Humans
  • Monitoring, Physiologic
  • Postoperative Care
  • Shock, Cardiogenic (etiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: